Genome_ENU_Point_mutation_discovery_in_the_Dove_271_mutant_mouse__Dove_271_mouse__-sc-2011-03-29T11:52:30Z-392
Genome_ENU_Point_mutation_discovery_in_the_Dove_271_mutant_mouse__Dove_271_mouse__
The Dove-271 mouse line was developed by William F. Dove (University of Wisconsin) by ENU treating animals to generate random genome-wide point mutations that were bred to homozygosity. We set out to discover these mutations by re-sequencing. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/
The goal of this study was to discover ENU induced point mutations by genome-wide re-sequencing. These mice represent a substrate or isogenic crosses.